Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Lifestyle Intervention to Reduce Body Weight and Systemic Inflammation Among World Trade Center Responders

17. november 2021 oppdatert av: Chrisa Arcan, PhD, MHS, MBA, RD, Stony Brook University

Lifestyle Intervention to Reduce Body Weight and Systemic Inflammation Among World Trade Center Responders With PTSD: Pilot Randomized Controlled Trial

The goal of this randomized control trial (RCT) is to test the feasibility and acceptability of a lifestyle intervention with a focus on implementing a high dose Mediterranean Diet protocol with physical activity to reduce systemic inflammation and body weight among WTC first responders having overweight/obesity and PTSD. The findings of this study will demonstrate the suitability of the proposed approach to reduce comorbidities among similar populations exposed to traumatic events; the findings will also inform the World Trade Center Health Program's extensive research and clinical efforts with the potential to provide a preventive care model to reduce systemic inflammation and related chronic disease among WTC responders with PTSD.

Studieoversikt

Detaljert beskrivelse

The proposed study will assess the feasibility and acceptability of a lifestyle intervention, including a Mediterranean Diet (MedDiet) with a physical activity (PA) component. The study is a pilot randomized control trial (RCT) among WTC responders with PTSD who have overweight and obesity. The 10-week intervention has two-arms, the intervention (MedDiet) with tips to increase PA (n=30) and control (care as usual n=30).

The high dose and high fidelity intervention combines several previously tested intervention modalities, including individual nutrition counseling, group cooking sessions, and communication and education through smartphones, including motivational texts & reminders, videos, teach-back surveys, and goal setting. While the main goal of the intervention is to assess the feasibility and acceptability of the intervention, the study will also assess changes in the overall dietary intake, the MedDiet score, and PA of the intervention group and between the two groups from baseline, post-intervention, and 3-month follow-up. The hypothesis is that the intervention group will experience a significant increase in the MedDiet score and PA activity from baseline to post-intervention; compared to the control group, the intervention group will achieve a significantly higher MedDiet score and will engage in more PA after the intervention.

Changes in body weight, inflammatory biomarkers, and prevalence of metabolic syndrome (MetS) in the intervention group and between the two groups from baseline to post-intervention will be explored; whether changes in inflammatory biomarkers, are moderated by changes in MetS, body weight, or MedDiet score will also be explored. The hypothesis is that the intervention group will experience a significant decrease in inflammatory biomarkers and prevalence in MetS from baseline to post-intervention; compared to the control group, the intervention group will achieve a significantly higher decrease in these measures; the decline in inflammatory biomarkers will be moderated by a reduction in the prevalence of MetS and/or increase in MedDiet score.

Studietype

Intervensjonell

Registrering (Faktiske)

62

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • New York
      • Commack, New York, Forente stater, 11725
        • World Trade Center Health Program Clinic

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

40 år til 65 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • BMI range: 27-40
  • PCL score: ≥40
  • MOCA score: ≥22
  • have a smartphone
  • able to follow a diet intervention
  • no physical disabilities which prevent exercising

Exclusion Criteria:

  • active cancer or history of GI-related cancer in the last 3 years
  • autoimmune disease
  • history of surgical weight loss

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Annen
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Mediterranean Diet & Physical Activity
Nutrition with a Physical Activity component. 10-week intervention implementing the Mediterranean Diet.

At the beginning of each week (1-10), members were sent a text message introducing the week and providing the link to the week's website. This website includes downloadable material for this group with recipes and other important nutrition information, as well as the weekly topic information and informative video. After receiving the link to the website, members received a Qualtrics survey with a teach-back question related to the video and a goal-setting question related to the topics of the week. At the end of each week, members received another Qualtrics survey with a question regarding the goal of the past week.

  • Visit 1: discuss Mediterranean diet score results from baseline and ways to improve
  • Visit 2: discuss anti-inflammatory diet scorecard and ways to improve
  • Discuss optimal dietary pattern (Med Diet pyramid handout)
  • Personal dietary and exercise goals, reviewed baseline intake form, social support, self-efficacy, challenges, or barriers to achieving goals
Andre navn:
  • Ernæringsintervensjon
Aktiv komparator: Usual Care
Usual care involves one-on-one monthly nutrition counseling
As part of usual care, members attended one-on-one monthly counseling sessions with the assigned dietitian and reviewed their current eating habits and physical activity, as well as other environmental factors that may be affecting their weight such as work, home environment, sleeping issues, and medications. After reviewing current practices, the RD provided medical nutrition therapy (MNT), a specific application of the Nutrition Care Process in clinical settings that focuses on the management of diseases (e.g. diabetes, heart disease, etc.). Specific dietary recommendations are based on the Bull's Eye Food Guide, used by Stony Brook University Hospital for outpatient nutrition counseling. Individuals in the standard care received more individualized calorie recommendations (usual care) than the Mediterranean diet group.
Andre navn:
  • Styre

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Mediterranean diet score
Tidsramme: 9 months

Participant's Mediterranean diet score is measured with a 14-item Mediterranean diet scale; possible score range 0-14.

The Mediterranean Diet questionnaire will be given at each participant visit with the dietitians and at baseline, post, and at 3-month follow up

9 months

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Physical activity
Tidsramme: 9 months
Daily step count is measured with Fitbit that was worn over seven days. Physical activity are measured at baseline, post-intervention, and 3-month follow up.
9 months
Body mass index (BMI)
Tidsramme: 9 months

Body mass index (weight/height square) will be objectively measured at baseline, post intervention and at 3-month follow up.

Body mass index: weight in kilograms/square of height in meters

9 months
Waist Circumference
Tidsramme: 9 months

Waist circumference is measured at baseline, post-intervention, and 3-month follow up.

Waist circumference cut off (Women>88cm; Men>102 cm)

9 months
Total cholesterol
Tidsramme: 9 months
Total cholesterol is measured at baseline, post-intervention, and at 3-months follow-up; reference range: 125 to 200mg/dL
9 months
oxidized LDL
Tidsramme: 9 months
Serum oxLDL is measured at baseline, post-intervention, and at 3-months follow-up; reference range: 10-170 ng/mL
9 months
HDL cholesterol
Tidsramme: 9 months

Serum HDL cholesterol was measured at baseline, post-intervention, and at 3-months follow-up;

At risk Men: Less than 40 mg/dL (1.0 mmol/L) Women: Less than 50 mg/dL (1.0 mmol/L)

9 months
Omega 3 fatty acid
Tidsramme: 9 months

Serum or plasma Free (Nonester) Fatty Acids Measured at baseline, post-intervention, and at 3-months follow-up. reference range:

Optimal >3.2 % Moderate 2.2-3.2 % High <2.2 %

9 months
Omega 6 to omega 3 ratio
Tidsramme: 9 months

Omega 6 is measured at baseline, post-intervention, and at 3-months follow-up;

Omega 6/omega 3 ratio:

Reference range: 5.7-21.3 (the lower the better)

9 months
HA1c
Tidsramme: 9 months

Serum Hemoglobin A1C (hA1C) is measured at baseline, post-intervention, and 3-month follow up.

hA1C: Normal: <5.7%

9 months
Cytokines
Tidsramme: 6 months

The following cytokines will be measured:

FNɣ, IL-1β, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-22 and TNFα, high-sensitivity C-reactive protein (hs-CRP) at >3mg/L.

The cytokines will be measured at two time points at baseline and post-intervention.

6 months
Psychosocial questionnaire
Tidsramme: 9 months
A total of 40 questions will be used to assess sedentary behaviors, home food availability, social support, self-efficacy, perceived barriers to adhering to lifestyle behaviors reflecting the behavioral strategies that will be addressed in the proposed intervention. The survey will be completed online at baseline, post-intervention and at 3-month follow up.
9 months
PCL score
Tidsramme: 9 months
Post Traumatic Stress Disorder symptoms will be tested with a PCL score. PCL is a 20-item self-report measure of current (past month) PTSD symptoms based on the DSM-V criteria. PCL will be measured at baseline, post intervention and at 3-month follow up
9 months

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. desember 2020

Primær fullføring (Forventet)

30. november 2021

Studiet fullført (Forventet)

30. november 2021

Datoer for studieregistrering

Først innsendt

7. august 2021

Først innsendt som oppfylte QC-kriteriene

17. november 2021

Først lagt ut (Faktiske)

30. november 2021

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

30. november 2021

Siste oppdatering sendt inn som oppfylte QC-kriteriene

17. november 2021

Sist bekreftet

1. november 2021

Mer informasjon

Begreper knyttet til denne studien

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere